R. H. Mereness (Asbestos Information Association) to Members Transmitting FDA Rule on Asbestos-Form Particles in Parenteral Drugs, with Federal Register Excerpt (1975)

A one-page memorandum from the Asbestos Information Association's executive director sends members the FDA regulation on asbestos-form particles in drugs for parenteral injection, as published in the Federal Register of March 14, 1975, and says a summary review will follow. The enclosure is the Federal Register cover page and the FDA final rule, which restricts asbestos-containing and other fiber-releasing filters in making injectable drugs and responds to comments on the 1973 proposal. The rule also delays final action on asbestos in talc and on asbestos filters for foods and non-parenteral drugs.

What the document holds

• Page 1: AIA memorandum from R. H. Mereness to members, 14 March 1975, enclosing the FDA regulation (stamped received March 17, 1975)
• Page 2: Federal Register cover and highlights, Vol. 40, No. 51, March 14, 1975
• Pages 3-7: FDA final rule, 21 CFR Part 133, Asbestos-Form Particles in Drugs for Parenteral Injection, with preamble, references and amended text, signed by the Commissioner of Food and Drugs, dated February 28, 1975

People and organizations

From R. H. Mereness (Executive Director, Asbestos Information Association) to Members (Members of the Asbestos Information Association).

• Robert H. Mereness (author)
• Asbestos Information Association/North America (its organization)
• DOT (named)
• EPA (named)
• Food and Drug Administration (named)
• U.S. Department of Health, Education, and Welfare (named)

Related pages

Pages on our site about what this document covers: EPA.

About this copy

This is document UC-3706 of the Union Carbide documents, documents produced and used as evidence in asbestos lawsuits against Union Carbide, 7 pages. Production numbers UCC 006269 to UCC 006275.